Dr. Frédéric Triebel Presenting at the World Immunotherapy Congress 2017 – Nasdaq
|
Dr. Frédéric Triebel Presenting at the World Immunotherapy Congress 2017
Nasdaq SYDNEY, Australia, Oct. 19, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) ("Prima") announces that Dr. Frédéric Triebel, Prima's Chief Scientific Officer & Medical Officer, will be giving an oral presentation on Prima's ongoing … |
